Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Hiroyuki Nakamura, Yuichiro Fujieda, Akinobu Nakamura & Tatsuya Atsumi. (2021) How should rheumatologists manage glucocorticoid-induced hyperglycemia?. Modern Rheumatology 31:3, pages 519-528.
Read now
Read now
Articles from other publishers (18)
Haijian Wu, Bowen Guo, Hongfa Zhong & Hui Ying. (2023) Natural drug asiaticoside inhibits osteoclast differentiation and promotes repair of steroid-induced osteonecrosis of femoral head via RANKL pathway. Materials Express 13:11, pages 1855-1861.
Crossref
Crossref
Danielle Brooks, Rifka Schulman-Rosenbaum, Megan Griff, Janice Lester & Cecilia C. Low Wang. (2022) Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic Review. Endocrine Practice 28:11, pages 1166-1177.
Crossref
Crossref
Jia-Xu Li & Carolyn L. Cummins. (2022) Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions. Nature Reviews Endocrinology 18:9, pages 540-557.
Crossref
Crossref
Marco Infante, Nathalia Padilla, Rodolfo Alejandro, Massimiliano Caprio, David Della-Morte, Andrea Fabbri & Camillo Ricordi. (2022) Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents. Medicina 58:5, pages 571.
Crossref
Crossref
Martin McDonnell, Richard J Harris, Florina Borca, Tilly Mills, Louise Downey, Suranga Dharmasiri, Mayank Patel, Benjamin Zare, Matt Stammers, Trevor R Smith, Richard Felwick, J R Fraser Cummings, Hang T T Phan & Markus Gwiggner. (2020) High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning. BMJ Open Gastroenterology 7:1, pages e000532.
Crossref
Crossref
Carina K. Klarskov, Helga Holm Schultz, Therese Wilbek Fabricius, Frederik Persson, Ulrik Pedersen‐Bjergaard & Peter Lommer Kristensen. (2020) Oral treatment of glucocorticoid‐induced diabetes mellitus: A systematic review. International Journal of Clinical Practice 74:8.
Crossref
Crossref
Güven Barış Cansu, Döndü Üsküdar Cansu, Bengür Taşkıran, Şule Yaşar Bilge, Muzaffer Bilgin & Cengiz Korkmaz. (2019) What is the optimal time for measuring glucose concentration to detect steroid-induced hyperglycemia in patients with rheumatic diseases?. Clinical Biochemistry 67, pages 33-39.
Crossref
Crossref
Al’bert Yu. Selimov, Lyudmila N. Eliseeva, Valeriya P. Kurinnaya & Sergei P. Oranskii. (2019) GLUCOSE EXCHANGE DISORDERS IN PATIENTS TAKING GLUCOCORTICOSTEROIDS: FEATURES OF CLINICAL MANIFESTATIONS AND CORRECTION. Kuban Scientific Medical Bulletin 26:1, pages 209-218.
Crossref
Crossref
Yoshia Miyawaki, Ken-Ei Sada, Yosuke Asano, Keigo Hayashi, Yuriko Yamamura, Sumie Hiramatsu, Keiji Ohashi, Michiko Morishita, Haruki Watanabe, Yoshinori Matsumoto, Katsue Sunahori-Watanabe, Tomoko Kawabata & Jun Wada. (2018) An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptin. Journal of Medical Case Reports 12:1.
Crossref
Crossref
Austin D. Chen, David Chi, Winona W. Wu, Sabine A. Egeler, Anmol S. Chattha, Alexandra Bucknor, Bernard T. Lee & Samuel J. Lin. (2018) The Influence of Connective Tissue Disease in Breast Reconstruction. Annals of Plastic Surgery 80:4, pages S182-S188.
Crossref
Crossref
Han Na Kim & Nestoras Mathioudakis. 2018. Endocrine and Metabolic Medical Emergencies. Endocrine and Metabolic Medical Emergencies
616
631
.
T. Imatoh, K. Sai, K. Hori, K. Segawa, J. Kawakami, M. Kimura & Y. Saito. (2017) Development of a novel algorithm for detecting glucocorticoid-induced diabetes mellitus using a medical information database. Journal of Clinical Pharmacy and Therapeutics 42:2, pages 215-220.
Crossref
Crossref
Yusuke Yata, Michihiro Hosojima, Hideyuki Kabasawa, Tomomi Ishikawa, Ryohei Kaseda, Noriaki Iino, Yoshiki Suzuki, Akihiko Saito & Ichiei Narita. (2017) The Assessment of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Glucocorticoid-induced Diabetes by Continuous Glucose Monitoring. Internal Medicine 56:19, pages 2555-2562.
Crossref
Crossref
Cindy Strehl, Johannes W J Bijlsma, Maarten de Wit, Maarten Boers, Nele Caeyers, Maurizio Cutolo, Bhaskar Dasgupta, William G Dixon, Rinie Geenen, Tom W J Huizinga, Alison Kent, Annette Ladefoged de Thurah, Joachim Listing, Xavier Mariette, David W Ray, Hans U Scherer, Raphaèle Seror, Cornelia M Spies, Simon Tarp, Dieter Wiek, Kevin L Winthrop & Frank Buttgereit. (2016) Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. Annals of the Rheumatic Diseases 75:6, pages 952-957.
Crossref
Crossref
Khalid Siddiqui & Shivani Tyagi. (2015) Genetics, genomics and personalized medicine in Type 2 diabetes: a perspective on the Arab region. Personalized Medicine 12:4, pages 417-431.
Crossref
Crossref
Takayuki Katsuyama, Ken-Ei Sada, Sayaka Namba, Haruki Watanabe, Eri Katsuyama, Toshio Yamanari, Jun Wada & Hirofumi Makino. (2015) Risk factors for the development of glucocorticoid-induced diabetes mellitus. Diabetes Research and Clinical Practice 108:2, pages 273-279.
Crossref
Crossref
George Habib, Yusri Dar-Esaif, Hashim Bishara, Suheil Artul, Samih Badarny, Mark Chernin & Adel Jabbour. (2014) The impact of corticosteroid treatment on hemoglobin A1C levels among patients with type-2 diabetes with chronic obstructive pulmonary disease exacerbation. Respiratory Medicine 108:11, pages 1641-1646.
Crossref
Crossref
Xiao-xia Liu, Xiao-ming Zhu, Qing Miao, Hong-ying Ye, Zhao-yun Zhang & Yi-ming Li. (2014) Hyperglycemia Induced by Glucocorticoids in Nondiabetic Patients: A Meta-Analysis. Annals of Nutrition and Metabolism 65:4, pages 324-332.
Crossref
Crossref